ClinicalTrials.gov
ClinicalTrials.gov Menu

Randomized Multicenter Study of 5 vs 6 Weekly Fraction of RT in the Treatment of SCC of the Head and Neck

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00534950
Recruitment Status : Completed
First Posted : September 26, 2007
Last Update Posted : February 25, 2016
Sponsor:
Information provided by (Responsible Party):
King Faisal Specialist Hospital & Research Center

Brief Summary:
Randomized multicenter study of 5 vs 6 weekly fraction of RT in the treatment of SCC of the head and neck

Condition or disease Intervention/treatment Phase
Carcinoma, Squamous Cell Radiation: 5 vs 6 weekly fraction of RT Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 200 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Study Start Date : September 2007
Actual Primary Completion Date : September 2015
Actual Study Completion Date : September 2015

Intervention Details:
    Radiation: 5 vs 6 weekly fraction of RT
    Chemotherapy


Primary Outcome Measures :
  1. safety [ Time Frame: 5 years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with SCC of the head and neck

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00534950


Locations
Saudi Arabia
KFSH&RC
Riyadh, Saudi Arabia, 1211
Sponsors and Collaborators
King Faisal Specialist Hospital & Research Center
Investigators
Principal Investigator: Nasser Al Rajhi, MD KFSH&RC

Responsible Party: King Faisal Specialist Hospital & Research Center
ClinicalTrials.gov Identifier: NCT00534950     History of Changes
Other Study ID Numbers: RAC#0981-019
First Posted: September 26, 2007    Key Record Dates
Last Update Posted: February 25, 2016
Last Verified: December 2011

Keywords provided by King Faisal Specialist Hospital & Research Center:
Randomized multicenter study of 5 vs 6 weekly fraction of RT in the treatment of SCC of the head and neck

Additional relevant MeSH terms:
Carcinoma, Squamous Cell
Carcinoma
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms
Neoplasms, Squamous Cell